Resources
Access further information about treatments and therapeutic areas of interest.
Graphic Abstracts
Overt HE
Rifaximin for the Reduction of Risk of Overt HE Recurrence
Bass NM, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362(12):1071-1081.
IBS-D
Two-Week Course of Rifaximin for Patients with IBS-D*
Pimentel M, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364(1):22-32.
Two-Week Repeat Rifaximin Course in Initial IBS-D Responders
Lembo A, et al. Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome. Gastroenterology. 2016;151(6):1113-1121.
Videos
IBS-D
Efficacy of rifaximin on bloating in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pooled analysis of three phase 3, randomized, placebo-controlled trials
Lacy BE. United European Gastroenterology (UEG) Week 2020, October 11-13, 2020, Virtual.